瑞典版简短患者报告结局量表在浅静脉功能不全中的验证
本研究在瑞典浅静脉功能不全患者中验证了7条目简短PROM(VARIShort)的心理测量学特性。结果显示VARIShort与26条目VEINES-QOL/Sym-S强相关(rs=-0.819; P<.001),内部一致性极好(Cronbach's α=0.93),对临床变化的反应性高(Cohen's d=1.17)。
要点
- VARIShort与VEINES-QOL/Sym-S强相关,可用于评估症状对生活质量的影响。
- VARIShort内部一致性极好(α=0.93),对临床变化反应性高(d=1.17)。
- VARIShort可用于瑞典SVI患者治疗前后的症状和结局评估。
核心结论
- 瑞典7条目PROM(VARIShort)可用于瑞典SVI患者症状评估和治疗后结局评价。
- VARIShort与26条目VEINES-QOL/Sym-S在评估SVI症状对生活质量影响方面表现一致。
研究设计与样本
- 于2018年1月至2019年10月在3家私立诊所和1家县医院连续招募CEAP临床分级≥C2的SVI患者。
- 队列1(252例)基线和队列2(138例)1周后完成VEINES-QOL/Sym-S和VARIShort。
- 队列3(106例)在静脉腔内手术前和术后8周完成VARIShort。
- 队列1、2、3平均年龄分别为58.3岁(范围20-93)、61.4岁(范围20-93)、57.2岁(范围20-89),女性分别占59%、55%、64%,CEAP C4分别占39%、46%、38%。
- 评估VARIShort的效度、重测信度、内部一致性信度、敏感性和反应性。
主要发现
- VEINES-QOL-S与VARIShort强相关(rs=-0.819; P<.001)。
- VARIShort内部一致性极好,Cronbach's α为0.93。
- VARIShort对临床变化反应性高,Cohen's d总体评分为1.17。
临床怎么用
- 在瑞典SVI患者中可使用VARIShort简短量表评估症状对生活质量的影响及治疗后效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patient-reported outcome measures (PROMs) are increasingly used to measure symptoms and treatment effects, and a short PROM is more user friendly. The aim of this study was to test whether a Swedish seven-item version of the PROM used in the Vascular Quality Initiative Varicose Vein Registry can be used to measure quality of life in a Swedish cohort of patients with superficial venous insufficiency (SVI) equally well as the 26-item Swedish version of the Venous Insufficiency Epidemiological and Economic Study on Quality of Life/Symptoms (VEINES-QOL/Sym-S) and measure treatment effect. METHODS: Consecutive patients with SVI and Clinical-Etiology-Anatomy-Pathophysiology (CEAP) clinical class ≥C2 were recruited at three private clinics and one county hospital between January 2018 and October 2019. The patients were asked to answer both the VEINES-QOL/Sym-S and the Swedish seven-item version, called VARIShort, at two assessment points, baseline (cohort 1, 252 patients) and 1 week later (cohort 2, 138 patients), and the VARIShort at baseline and 8 weeks after an endovenous procedure (cohort 3, 106 patients). The mean age was 58.3 years (range, 20-93 years), 61.4 years (range, 20-93 years), and 57.2 years (range, 20-89 years) in cohorts 1, 2, and 3, respectively; the majority were female (59%, 55%, and 64%), and most were CEAP C4 (39%, 46%, and 38%). The VARIShort was evaluated with regard to its validity, test-retest reliability, internal consistency reliability, sensitivity, and responsiveness. RESULTS: There was a strong correlation between the VEINES-QOL-S and the VARIShort (rs = -0.819; P < .001). The VARIShort showed both excellent internal consistency with Cronbach's α of 0.93 and a high response to clinical change as measured with Cohen's d, overall score of 1.17. CONCLUSIONS: The Swedish seven-item PROM, the VARIShort, may be used for assessment of symptoms of SVI and outcome after treatment in Swedish SVI patients. The short PROM shows degree of SVI symptom impact on quality of life in the same manner as the 26-item VEINES-QOL/Sym-S.
引用
- Hultman KH, Sinabulya H, Blomgren L, et al. Validation of a Swedish version of a short patient-reported outcome measure for superficial venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32736096. doi:10.1016/j.jvsv.2020.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。